About Allucent
Allucent is a company based in Cary (United States) founded in 1994. It operates as a Professional Services and Managed Services. The company has 177 employees as of April 09, 2024. Allucent offers products and services including Clinical Development, Regulatory Strategy, Clinical Pharmacology, and Drug Safety & Pharmacovigilance. Allucent operates in a competitive market with competitors including Celgene, Centivo, iMedX, Syneos Health and Medelis WCCT Global, among others.
- Headquarter Cary, United States
- Employees 177 as on 09 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Allucent (India) Private Limited
- Date of Incorporation 27 Nov, 2002
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
$4.25 M (USD)74.23as on Mar 31, 2023
-
Net Profit
$293.73 K (USD)78.82as on Mar 31, 2023
-
EBITDA
$796.45 K (USD)127.04as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
European Union
& 2 more
-
Employee Count
177
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Allucent
Allucent offers a comprehensive portfolio of products and services, including Clinical Development, Regulatory Strategy, Clinical Pharmacology, and Drug Safety & Pharmacovigilance.
Clinical trials are managed for biotech drug development.
Regulatory guidance is provided for drug approval processes.
Pharmacokinetic studies are conducted for drug development insights.
Drug safety monitoring is ensured during clinical trials.
People of Allucent
Unlock access to complete
Unlock access to complete
Leadership Team
22 people
Sales and Marketing
21 people
Senior Team
17 people
Software Development Team
15 people
Data Analysis and Operations Team
9 people
Operations Team
4 people
Finance and Accounting
4 people
Product Management Team
3 people
Unlock access to complete
Funding Insights of Allucent
Investors in Allucent
Allucent has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Water Street and JLL Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Water Street is engaged in strategic investments in healthcare sectors.
|
Locked | Locked | Locked | |
|
JLL Partners is engaged in middle-market business transformation and investment.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Allucent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Allucent
Investment portfolio details for Allucent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Allucent
Detailed financials for Allucent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Allucent Comparisons
Peer comparison for Allucent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Allucent
Allucent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Centivo, iMedX, Syneos Health and Medelis WCCT Global, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Provider of self funded health plan
|
|
| Locked | Locked | Locked |
Revenue cycle management platform is provided to healthcare providers.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
Detailed competitors of Allucent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Allucent
Complete news archive for Allucent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Allucent
Allucent was founded in 1994 and raised its 1st funding round 23 years after it was founded.
Allucent is headquartered in Cary, United States. It is registered at Cary, North Carolina, United States.
Mark A Goldberg is the current CEO of Allucent.
As of Apr 09, 2024, the latest employee count at Allucent is 177.
Annual revenue of Allucent is $4.25M as on Mar 31, 2023.
Allucent is established as a global contract research organization focused on supporting small and mid-sized biotech companies in drug development. Services are provided across clinical development, regulatory strategy, clinical pharmacology, and pharmacovigilance. Operations are conducted in over 60 countries, addressing complex therapeutic areas such as oncology, neuroscience, and rare diseases. Comprehensive solutions are offered from early-phase studies to post-marketing surveillance, ensuring efficient trial management and regulatory compliance. Expertise is applied to help navigate challenges in clinical research, with a commitment to bringing innovative therapies to patients worldwide.
Allucent's top competitors include Centivo, Emmes and Syneos Health.
Allucent offers Clinical Development, Regulatory Strategy, Clinical Pharmacology, and Drug Safety & Pharmacovigilance.
Allucent has 3 investors. Key investors include European Union, Water Street, and JLL Partners.